IndraLab

Statements

CYLD inhibits NFKBIA. 2 / 2

| 2

reach

"Treatment with BAY 11-7085, a known NF-kappaB antagonist that blocks IkappaBalpha phosphorylation and NF-kappaB transactivation, effectively abrogated the CYLD siRNA induced IkappaBalpha degradation."

29050336

➶

reach

"While the CYLD deficiency slightly decreased the basal expression levels of IkappaBalpha and IkappaBbeta proteins, it did not affect the basal expression of IkappaBepsilon in RASMCs (XREF_FIG)."

22406061

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

CYLD inhibits NFKBIA. 2 / 2

INDRA sources:

Databases

Reading